115,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
58 °P sammeln
  • Gebundenes Buch

This book brings together dozens of top experts in the field of epigenetics in China and abroad, including two academics of the Chinese Academy of Sciences, seven winners of The National Science Fund for Distinguished Young Scholars, numerous outstanding young researchers, and experts in the Thousand Talents Plan, among others. It comprehensively and systematically expands on the latest research findings in epigenetics and precision medicine. The authors of this book combined their research findings and experience to explain concepts, mechanisms, and new technologies in epigenetic regulation…mehr

Produktbeschreibung
This book brings together dozens of top experts in the field of epigenetics in China and abroad, including two academics of the Chinese Academy of Sciences, seven winners of The National Science Fund for Distinguished Young Scholars, numerous outstanding young researchers, and experts in the Thousand Talents Plan, among others. It comprehensively and systematically expands on the latest research findings in epigenetics and precision medicine. The authors of this book combined their research findings and experience to explain concepts, mechanisms, and new technologies in epigenetic regulation and their immense prospects in the precise diagnosis and treatment of major diseases. The book also covers the fundamentals and translational research like DNA methylation, histone modification, higher-order chromatin structure, non-coding RNA, RNA modification, stem cell biology, and the epigenetics of traditional Chinese medicine. This book can serve as an important reference text for scientists and clinicians involved in basic and clinical research in epigenetics and those who are working to overcome major diseases.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Jingde Zhu was born in 1950. He is a Professor at the Tumor Epigenetics Laboratory, Anhui Provincial Cancer Hospital. His main research interests are in tumors and epigenetics. He has won awards and honors and made important contributions to epigenome research in China and globally. He has also served as a member of the American Association for Cancer Research (AACR) Epigenomics Professional Committee (2006-2012) and co-founder of the Asian Epigenome Alliance. He has published more than 70 papers in international academic journals and obtained many US patents.